PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930096
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930096
DNA Synthesis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of DNA synthesis Market
The global DNA synthesis market is witnessing significant growth driven by the rising demand for synthetic DNA in research, diagnostics, and therapeutic applications. According to Fortune Business Insights, the market was valued at USD 5.19 billion in 2025, and it is expected to grow to USD 5.95 billion in 2026. With an anticipated CAGR of 19.09% from 2026 to 2034, the market is projected to reach USD 24.06 billion by 2034, reflecting the increasing adoption of synthetic DNA for gene therapy, molecular diagnostics, and personalized medicine. North America dominated the market in 2025, holding 54.61% market share, due to robust R&D infrastructure, high adoption of precision medicine, and active initiatives by leading companies to expand services and launch innovative products.
DNA synthesis involves the artificial creation of DNA molecules, including oligonucleotides, genes, and DNA fragments. These synthetic DNA products enable the development of new drugs, vaccines, gene therapies for genetic disorders, and molecular diagnostic tools such as PCR assays and nucleic-acid-based sensors. The rising prevalence of chronic, genetic, and rare diseases, along with increased healthcare expenditure and awareness of personalized treatment, is propelling demand for synthetic DNA globally.
Market Trends
Technological advancements have been a significant driver of market growth. Companies are focusing on faster, more accurate, and cost-effective DNA synthesis methods, including automated microfluidics systems, which reduce turnaround time and labor requirements. For example, in August 2023, Atantares raised USD 13.9 million to develop molecular chips for high-throughput enzymatic DNA synthesis, demonstrating the trend toward automation and efficiency.
During the COVID-19 pandemic, demand for synthetic DNA surged due to the urgent need for molecular diagnostic tests and vaccine development. Post-pandemic, the market stabilized, but the increased focus on precision medicine and gene-based therapeutics has maintained strong growth momentum.
Market Growth Factors
The growing use of DNA synthesis in novel therapeutics, molecular diagnostics, and R&D initiatives is driving market expansion. Gene synthesis is particularly in demand due to its customizable applications for pharmaceutical and biotechnology companies. For instance, the gene synthesis segment accounted for 74.31% of the market in 2026. Oligonucleotide synthesis is also gaining traction due to its use in diagnostics, therapeutics, and gene therapy.
Healthcare spending and investments in precision medicine are further enhancing market growth. Gene synthesis allows tailored treatments for diseases such as cancer and genetic disorders, aligning with government initiatives in countries like the U.K., where public R&D spending is projected to reach USD 27.36 billion by 2025.
Market Restraints
Despite rapid growth, the market faces challenges, including a lack of clear regulatory frameworks and a shortage of skilled laboratory personnel. For instance, in September 2022, the European Medicines Agency highlighted the need for guidelines on synthetic oligonucleotides, reflecting regulatory uncertainties that may slow product launches.
Segmentation Analysis
By Product & Service: The services segment dominated the market with 72.76% share in 2026, driven by providers offering high-purity, cost-effective, and customized DNA solutions. The products segment, including instruments and reagents & consumables, also holds a significant portion, bolstered by new launches such as the BioXp Select DNA Cloning kit by Telesis Bio Inc. in May 2023.
By Type: Gene synthesis holds the largest share due to customizable sequences and high demand from research institutions and industry. Oligonucleotide synthesis is growing due to increasing use in diagnostics, therapeutics, and molecular biology applications.
By Application: The diagnostics segment dominated in 2026 with 50.26% market share, driven by molecular diagnostics for diseases such as cancer and infectious diseases. The therapeutics segment is growing due to gene therapy and vaccine development, while R&D continues to expand through drug discovery, cloning, and gene editing initiatives.
By End-User: Pharmaceutical and biotechnology companies hold the largest share, leveraging synthetic DNA for novel therapeutics and gene therapy development. Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) follow closely, offering specialized production and services. Academic and research institutes are also increasing adoption.
Regional Insights
North America dominated with USD 2.83 billion in 2025, growing to USD 3.22 billion in 2026, driven by high prevalence of chronic and genetic diseases, advanced research infrastructure, and increasing personalized medicine initiatives. The U.S. market alone is projected at USD 3.03 billion in 2026. Europe holds a significant market share, with the U.K. and Germany projected to reach USD 0.22 billion and USD 0.32 billion, respectively, in 2026, supported by strong R&D collaborations. The Asia Pacific region is anticipated to witness the highest CAGR, with China, Japan, and India projected at USD 0.43 billion, USD 0.24 billion, and USD 0.13 billion, respectively, in 2026, due to growing biotech infrastructure, research collaborations, and increasing adoption of synthetic DNA technologies. Latin America and the Middle East & Africa are expected to grow moderately, driven by government initiatives to enhance biotechnology research.
Key Players & Developments
Prominent market players include Thermo Fisher Scientific, Integrated DNA Technologies, GenScript, Eurofins Scientific, Azenta, and Twist Bioscience. Companies focus on strategic collaborations, facility expansions, and new service launches. For instance, in November 2023, Twist Bioscience launched Twist Express Genes, offering rapid gene synthesis with accelerated delivery.
Conclusion
The global DNA synthesis market is set for robust growth, expanding from USD 5.19 billion in 2025 to USD 24.06 billion by 2034, driven by technological advancements, growing demand in diagnostics, therapeutics, and research, and increasing investments in synthetic biology. With innovations in gene synthesis, growing adoption of oligonucleotides, and regional expansion, the market is poised to play a critical role in precision medicine and the future of biotechnology worldwide.
Segmentation By Product & Service
- Products
- Instruments
- Reagents & Consumables
- Services
By Type
- Oligonucleotide Synthesis
- Gene Synthesis
By Application
- Diagnostics
- Infectious Diseases
- Cancer
- Others
- Therapeutics
- Gene Therapy
- Preventive Medicine
- Others
- Research & Development
- Cloning and Gene Editing
- Drug Discovery & Development
- Others
By End-user
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs) & Contract Development and Manufacturing Organizations (CDMOs)
- Others
By Region
- North America (By Product & Service, By Type, By Application, By End-user, and By Country)
- U.S.
- Canada
- Europe (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
- U.K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Product & Service, By Type, By Application, By End-user, and By Country/Sub-Region)
- GCC
- South Africa
- Rest of Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Technological Developments in the DNA Synthesis
- 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
- 4.3. New Product Launches
- 4.4. Impact of COVID-19 on the DNA Synthesis Market
5. Global DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product & Service
- 5.1.1. Products
- 5.1.1.1. Instruments
- 5.1.1.2. Reagents & Consumables
- 5.1.2. Services
- 5.1.1. Products
- 5.2. Market Analysis, Insights and Forecast - By Type
- 5.2.1. Oligonucleotide Synthesis
- 5.2.2. Gene Synthesis
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Diagnostics
- 5.3.1.1. Infectious Diseases
- 5.3.1.2. Cancer
- 5.3.1.3. Others
- 5.3.2. Therapeutics
- 5.3.2.1. Gene Therapy
- 5.3.2.2. Preventive Medicine
- 5.3.2.3. Others
- 5.3.3. Research & Development
- 5.3.3.1. Cloning and Gene Editing
- 5.3.3.2. Drug Discovery & Development
- 5.3.3.3. Others
- 5.3.1. Diagnostics
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Pharmaceutical & Biotechnology Companies
- 5.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product & Service
- 6.1.1. Products
- 6.1.1.1. Instruments
- 6.1.1.2. Reagents & Consumables
- 6.1.2. Services
- 6.1.1. Products
- 6.2. Market Analysis, Insights and Forecast - By Type
- 6.2.1. Oligonucleotide Synthesis
- 6.2.2. Gene Synthesis
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Diagnostics
- 6.3.1.1. Infectious Diseases
- 6.3.1.2. Cancer
- 6.3.1.3. Others
- 6.3.2. Therapeutics
- 6.3.2.1. Gene Therapy
- 6.3.2.2. Preventive Medicine
- 6.3.2.3. Others
- 6.3.3. Research & Development
- 6.3.3.1. Cloning and Gene Editing
- 6.3.3.2. Drug Discovery & Development
- 6.3.3.3. Others
- 6.3.1. Diagnostics
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Pharmaceutical & Biotechnology Companies
- 6.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product & Service
- 7.1.1. Products
- 7.1.1.1. Instruments
- 7.1.1.2. Reagents & Consumables
- 7.1.2. Services
- 7.1.1. Products
- 7.2. Market Analysis, Insights and Forecast - By Type
- 7.2.1. Oligonucleotide Synthesis
- 7.2.2. Gene Synthesis
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Diagnostics
- 7.3.1.1. Infectious Diseases
- 7.3.1.2. Cancer
- 7.3.1.3. Others
- 7.3.2. Therapeutics
- 7.3.2.1. Gene Therapy
- 7.3.2.2. Preventive Medicine
- 7.3.2.3. Others
- 7.3.3. Research & Development
- 7.3.3.1. Cloning and Gene Editing
- 7.3.3.2. Drug Discovery & Development
- 7.3.3.3. Others
- 7.3.1. Diagnostics
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Pharmaceutical & Biotechnology Companies
- 7.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product & Service
- 8.1.1. Products
- 8.1.1.1. Instruments
- 8.1.1.2. Reagents & Consumables
- 8.1.2. Services
- 8.1.1. Products
- 8.2. Market Analysis, Insights and Forecast - By Type
- 8.2.1. Oligonucleotide Synthesis
- 8.2.2. Gene Synthesis
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Diagnostics
- 8.3.1.1. Infectious Diseases
- 8.3.1.2. Cancer
- 8.3.1.3. Others
- 8.3.2. Therapeutics
- 8.3.2.1. Gene Therapy
- 8.3.2.2. Preventive Medicine
- 8.3.2.3. Others
- 8.3.3. Research & Development
- 8.3.3.1. Cloning and Gene Editing
- 8.3.3.2. Drug Discovery & Development
- 8.3.3.3. Others
- 8.3.1. Diagnostics
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Pharmaceutical & Biotechnology Companies
- 8.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product & Service
- 9.1.1. Products
- 9.1.1.1. Instruments
- 9.1.1.2. Reagents & Consumables
- 9.1.2. Services
- 9.1.1. Products
- 9.2. Market Analysis, Insights and Forecast - By Type
- 9.2.1. Oligonucleotide Synthesis
- 9.2.2. Gene Synthesis
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Diagnostics
- 9.3.1.1. Infectious Diseases
- 9.3.1.2. Cancer
- 9.3.1.3. Others
- 9.3.2. Therapeutics
- 9.3.2.1. Gene Therapy
- 9.3.2.2. Preventive Medicine
- 9.3.2.3. Others
- 9.3.3. Research & Development
- 9.3.3.1. Cloning and Gene Editing
- 9.3.3.2. Drug Discovery & Development
- 9.3.3.3. Others
- 9.3.1. Diagnostics
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Pharmaceutical & Biotechnology Companies
- 9.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa DNA Synthesis Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product & Service
- 10.1.1. Products
- 10.1.1.1. Instruments
- 10.1.1.2. Reagents & Consumables
- 10.1.2. Services
- 10.1.1. Products
- 10.2. Market Analysis, Insights and Forecast - By Type
- 10.2.1. Oligonucleotide Synthesis
- 10.2.2. Gene Synthesis
- 10.3. Market Analysis, Insights and Forecast - By Application
- 10.3.1. Diagnostics
- 10.3.1.1. Infectious Diseases
- 10.3.1.2. Cancer
- 10.3.1.3. Others
- 10.3.2. Therapeutics
- 10.3.2.1. Gene Therapy
- 10.3.2.2. Preventive Medicine
- 10.3.2.3. Others
- 10.3.3. Research & Development
- 10.3.3.1. Cloning and Gene Editing
- 10.3.3.2. Drug Discovery & Development
- 10.3.3.3. Others
- 10.3.1. Diagnostics
- 10.4. Market Analysis, Insights and Forecast - By End User
- 10.4.1. Pharmaceutical & Biotechnology Companies
- 10.4.2. Contract Research Organizations (CROs) & Contract development and manufacturing organizations (CDMOs)
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Thermo Fisher Scientific Inc.
- 11.2.1.1. Overview
- 11.2.1.2. Products & services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Integrated DNA Technologies, Inc. (Danaher)
- 11.2.2.1. Overview
- 11.2.2.2. Products & services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Eurofins Scientific
- 11.2.3.1. Overview
- 11.2.3.2. Products & services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. GenScript
- 11.2.4.1. Overview
- 11.2.4.2. Products & services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Azenta, Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products & services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. LGC Limited
- 11.2.6.1. Overview
- 11.2.6.2. Products & services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Biomatik
- 11.2.7.1. Overview
- 11.2.7.2. Products & services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Telesis Bio Inc.
- 11.2.8.1. Overview
- 11.2.8.2. Products & services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Twist Bioscience
- 11.2.9.1. Overview
- 11.2.9.2. Products & services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Bioneer Corporation
- 11.2.10.1. Overview
- 11.2.10.2. Products & services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.1. Thermo Fisher Scientific Inc.
List of Tables
- Table 01: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
- Table 02: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
- Table 03: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 04: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 05: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
- Table 06: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
- Table 07: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
- Table 08: Global DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 09: Global DNA Synthesis Market Revenue (USD billion) Forecast, By Region, 2021-2034
- Table 10: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
- Table 11: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
- Table 12: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 13: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 14: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
- Table 15: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
- Table 16: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
- Table 17: North America DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 18: North America DNA Synthesis Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 19: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
- Table 20: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
- Table 21: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 22: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 23: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
- Table 24: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
- Table 25: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
- Table 26: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 27: Europe DNA Synthesis Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
- Table 28: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
- Table 29: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
- Table 30: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 31: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 32: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
- Table 33: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
- Table 34: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
- Table 35: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 36: Asia Pacific DNA Synthesis Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
- Table 37: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
- Table 38: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
- Table 39: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 40: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 41: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
- Table 42: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
- Table 43: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
- Table 44: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 45: Latin America DNA Synthesis Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
- Table 46: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Product & Service, 2021-2034
- Table 47: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Products, 2021-2034
- Table 48: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Type, 2021-2034
- Table 49: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Application, 2021-2034
- Table 50: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Diagnostics, 2021-2034
- Table 51: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Therapeutics, 2021-2034
- Table 52: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By Research & Development, 2021-2034
- Table 53: Middle East & Africa DNA Synthesis Market Revenue (USD billion) Forecast, By End-user, 2021-2034
- Table 54: Middle East & Africa DNA Synthesis Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
List of Figures
- Figure 01: Global DNA Synthesis Market Revenue Breakdown (USD billion, %), by Region, 2025 & 2034
- Figure 02: Global DNA Synthesis Market Value Share (%), By Product & Service, 2025 & 2034
- Figure 03: Global DNA Synthesis Market Value Share (%), By Type, 2025 & 2034
- Figure 04: Global DNA Synthesis Market Value Share (%), By Application, 2025 & 2034
- Figure 05: Global DNA Synthesis Market Value Share (%), By End-user, 2025 & 2034
- Figure 06: Global DNA Synthesis Market Value Share (%), By Region, 2025 & 2034
- Figure 07: North America DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
- Figure 08: North America DNA Synthesis Market Value Share (%), By Product & Service, 2025
- Figure 09: North America DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
- Figure 10: North America DNA Synthesis Market Value Share (%), By Type, 2025
- Figure 11: North America DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
- Figure 12: North America DNA Synthesis Market Value Share (%), By Application, 2025
- Figure 13: North America DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
- Figure 14: North America DNA Synthesis Market Value Share (%), By End-user, 2025
- Figure 15: North America DNA Synthesis Market Value (USD billion), By Country, 2025 & 2034
- Figure 16: North America DNA Synthesis Market Value Share (%), By Country, 2025
- Figure 17: Europe DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
- Figure 18: Europe DNA Synthesis Market Value Share (%), By Product & Service, 2025
- Figure 19: Europe DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
- Figure 20: Europe DNA Synthesis Market Value Share (%), By Type, 2025
- Figure 21: Europe DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
- Figure 22: Europe DNA Synthesis Market Value Share (%), By Application, 2025
- Figure 23: Europe DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
- Figure 24: Europe DNA Synthesis Market Value Share (%), By End-user, 2025
- Figure 25: Europe DNA Synthesis Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
- Figure 26: Europe DNA Synthesis Market Value Share (%), By Country/Sub-Region, 2025
- Figure 27: Asia Pacific DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
- Figure 28: Asia Pacific DNA Synthesis Market Value Share (%), By Product & Service, 2025
- Figure 29: Asia Pacific DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
- Figure 30: Asia Pacific DNA Synthesis Market Value Share (%), By Type, 2025
- Figure 31: Asia Pacific DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
- Figure 32: Asia Pacific DNA Synthesis Market Value Share (%), By Application, 2025
- Figure 33: Asia Pacific DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
- Figure 34: Asia Pacific DNA Synthesis Market Value Share (%), By End-user, 2025
- Figure 35: Asia Pacific DNA Synthesis Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
- Figure 36: Asia Pacific DNA Synthesis Market Value Share (%), By Country/ Sub-Region, 2025
- Figure 37: Latin America DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
- Figure 38: Latin America DNA Synthesis Market Value Share (%), By Product & Service, 2025
- Figure 39: Latin America DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
- Figure 40: Latin America DNA Synthesis Market Value Share (%), By Type, 2025
- Figure 41: Latin America DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
- Figure 42: Latin America DNA Synthesis Market Value Share (%), By Application, 2025
- Figure 43: Latin America DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
- Figure 44: Latin America DNA Synthesis Market Value Share (%), By End-user, 2025
- Figure 45: Latin America DNA Synthesis Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
- Figure 46: Latin America DNA Synthesis Market Value Share (%), By Country/ Sub-Region, 2025
- Figure 47: Middle East & Africa DNA Synthesis Market Value (USD billion), By Product & Service, 2025 & 2034
- Figure 48: Middle East & Africa DNA Synthesis Market Value Share (%), By Product & Service, 2025
- Figure 49: Middle East & Africa DNA Synthesis Market Value (USD billion), By Type, 2025 & 2034
- Figure 50: Middle East & Africa DNA Synthesis Market Value Share (%), By Type, 2025
- Figure 51: Middle East & Africa DNA Synthesis Market Value (USD billion), By Application, 2025 & 2034
- Figure 52: Middle East & Africa DNA Synthesis Market Value Share (%), By Application, 2025
- Figure 53: Middle East & Africa DNA Synthesis Market Value (USD billion), By End-user, 2025 & 2034
- Figure 54: Middle East & Africa DNA Synthesis Market Value Share (%), By End-user, 2025
- Figure 55: Middle East & Africa DNA Synthesis Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
- Figure 56: Middle East & Africa DNA Synthesis Market Value Share (%), By Country/ Sub-Region, 2025
- Figure 57: Global DNA Synthesis Market Share Analysis, By Company, 2025
